NasdaqGM:AUPHBiotechs
Assessing Aurinia Pharmaceuticals (AUPH) Valuation After Mixed Recent Share Price Performance
Aurinia Pharmaceuticals (NasdaqGM:AUPH) has been drawing attention after recent share price moves, with the stock showing mixed returns over the past month and past 3 months as investors reassess its autoimmune drug portfolio.
See our latest analysis for Aurinia Pharmaceuticals.
At a share price of US$14.83, Aurinia’s recent 1 day share price return of about 3% and 7 day return above 4% contrast with a weaker 90 day share price return. The 1 year total shareholder return above 80% suggests...